Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Standard Chem & Pharm Co LtdfiledCriticalStandard Chem & Pharm Co Ltd
Priority to TW092121023ApriorityCriticalpatent/TW200503728A/en
Publication of TW200503728ApublicationCriticalpatent/TW200503728A/en
Application grantedgrantedCritical
Publication of TWI297608BpublicationCriticalpatent/TWI297608B/zh
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
This invention relates to a suspension pharmaceutical composition containing budesonide, comprising a therapeutically effective amount of miniaturized budesonide, microcrystalline cellulose with a particle size less than 100 mgr;m, xanthan gum, and sodium benzoate as a preservative. The present invention also relates to a method for producing a suspension pharmaceutical composition containing budesonide.
TW092121023A2003-07-312003-07-31Suspension pharmaceutical composition containing budesonide and method for producing the same
TW200503728A
(en)
Pharmaceutical composition comprising N-((1-N-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-A)indole-10carboxamide or salt and process for preparing thereof comprising dry granulation
Fondaparinux sodium composition of high purity, method for production of said composition and pharmaceutical compositions containing the same as active ingredient
Composition comprising at least one anticancer drug and at least one polymer and reducing chemotherapy-induced alopecia, process for the preparation thereof